Vimarsana
Biggest News Aggregation in the World

Page 21 - Trial Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trial Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trial Network Today - Breaking & Trending Today

INOVIO Further Expands INNOVATE Phase 3 Trial for COVID-19 DNA Vaccine Candidate INO-4800 With Regulatory Authorization from India - Vimarsana News

INOVIO Further Expands INNOVATE Phase 3 Trial for COVID-19 DNA Vaccine Candidate INO-4800 With Regulatory Authorization from India

Published: November 3, 2021

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from...

Source: prnewswire.com
Related Topics:
United StatesSouth KoreaBen MatoneJeff RichardsonKaneka EurogentecJ Joseph KimWalter Reed Army Institute Of ResearchNational Cancer InstituteNational Institute Of AllergyPlumbline Life SciencesMelinda Gates FoundationCoalition For Epidemic Preparedness InnovationsAdvaccine Biopharmaceuticals Suzhou Co LtdIndia Central Drugs Standard Control OrganizationNuclear DefenseDefense ConsortiumParker Institute For Cancer ImmunotherapyInternational Vaccine InstituteDefense Health AgencyNational Institutes Of HealthNuclear Defense Department OfHealth AffairsApollobio CorporationVaccines Trial NetworkOffice Of The
INOVIO Completes Enrollment of Phase 1B Clinical Trial for its DNA Vaccine Candidate Against Lassa Fever, INO-4500, in West Africa - Vimarsana News

INOVIO Completes Enrollment of Phase 1B Clinical Trial for its DNA Vaccine Candidate Against Lassa Fever, INO-4500, in West Africa

Published: October 26, 2021

/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from...

Source: prnewswire.com
Related Topics:
United StatesSouth KoreaGreater AccraSierra LeoneBen MatoneKwadwo KoranBrosh Nissimovt LassaMelanie SavilleKaneka EurogentecWest Central AfricaDorothy YeboahLaurent HumeauJeff RichardsonPaesslers LassaKwadwoa KoramWalter Reed Army Institute Of ResearchNational Cancer InstituteNoguchi Memorial Institute For Medical ResearchNational Institute Of AllergyPlumbline Life SciencesMelinda Gates FoundationCoalition For Epidemic Preparedness InnovationsHealth Topics Lassa FeverParker Institute For Cancer ImmunotherapyInternational Vaccine Institute
INOVIO Announces Collaboration with Colombia; Memorandum of Understanding Focuses on Protecting Against COVID-19 and Supporting Broader Health Preparedness Initiatives - Vimarsana News

INOVIO Announces Collaboration with Colombia; Memorandum of Understanding Focuses on Protecting Against COVID-19 and Supporting Broader Health Preparedness Initiatives

Published: October 24, 2021

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from...

Source: prnewswire.com
Related Topics:
United StatesSouth KoreaRepublic Of ColombiaFernando Ruiz GomezBen MatoneJeff RichardsonKaneka EurogentecWalter Reed Army Institute Of ResearchNational Cancer InstituteNational Institute Of AllergyMinistry Of HealthPlumbline Life SciencesMelinda Gates FoundationCoalition For Epidemic Preparedness InnovationsAdvaccine Biopharmaceuticals Suzhou Co LtdDefense ConsortiumParker Institute For Cancer ImmunotherapyInternational Vaccine InstituteNational Institutes Of HealthNuclear Defense Department OfApollobio CorporationVaccines Trial NetworkUniversity Of PennsylvaniaWistar InstituteLatin America
INOVIO Announces Online Preprint Publication of Homologous Boosting Data for its COVID-19 DNA Vaccine Candidate, INO-4800 - Vimarsana News

INOVIO Announces Online Preprint Publication of Homologous Boosting Data for its COVID-19 DNA Vaccine Candidate, INO-4800

Published: October 12, 2021

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from...

Source: prnewswire.com
Related Topics:
South KoreaBen MatoneJeff RichardsonKaneka EurogentecJ Joseph KimWalter Reed Army Institute Of ResearchNational Cancer InstituteNational Institute Of AllergyPlumbline Life SciencesMelinda Gates FoundationCoalition For Epidemic Preparedness InnovationsDefense ConsortiumParker Institute For Cancer ImmunotherapyInternational Vaccine InstituteHealth SciencesNational Institutes Of HealthNuclear Defense Department OfApollobio CorporationVaccines Trial NetworkUniversity Of PennsylvaniaWistar InstituteDurable Immune Responses CapableBeing BoostedLabel TrialAdvaccine Biopharmaceuticals
INOVIO Expands INNOVATE Phase 3 for INO-4800, its DNA Vaccine Candidate for COVID-19, to include Colombia following Regulatory Authorization - Vimarsana News

INOVIO Expands INNOVATE Phase 3 for INO-4800, its DNA Vaccine Candidate for COVID-19, to include Colombia following Regulatory Authorization

Published: October 12, 2021

INOVIO Expands INNOVATE Phase 3 for INO-4800, its DNA Vaccine Candidate for COVID-19, to include Colombia following Regulatory Authorization - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com
Related Topics:
United StatesSouth KoreaBen MatoneJeff RichardsonKaneka EurogentecJ Joseph KimWalter Reed Army Institute Of ResearchNational Cancer InstituteNational Institute Of AllergyPlumbline Life SciencesMelinda Gates FoundationNational FoodCoalition For Epidemic Preparedness InnovationsAdvaccine Biopharmaceuticals Suzhou Co LtdNuclear DefensePharmaceuticals IncDefense ConsortiumParker Institute For Cancer ImmunotherapyInternational Vaccine InstituteDefense Health AgencyNational Institutes Of HealthDrug Surveillance InstituteExchange CommissionNuclear Defense Department OfHealth Affairs